Anlotinib as a maintenance treatment for advanced soft tissue sarcoma after first-line chemotherapy (ALTER-S006): a multicentre, open-label, single-arm, phase 2 trial
Open Access
- 21 September 2023
- journal article
- research article
- Published by Elsevier in eClinicalMedicine
- Vol. 64, 102240
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2021YFC2400600 / 2021YFC2400601)
- National Natural Science Foundation of China (82102776)
- National Natural Science Foundation of China (82072958)
- National Natural Science Foundation of China (82272699)
This publication has 49 references indexed in Scilit:
- Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trialThe Lancet Oncology, 2014
- Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior ChemotherapyJournal of Clinical Oncology, 2013
- Primary gastric synovial sarcoma: molecular diagnosis and prediction of prognosisClinical Journal of Gastroenterology, 2013
- Phase 2 Southwest Oncology Group‐directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomasCancer, 2011
- Trends in survival for patients with metastatic soft‐tissue sarcomaCancer, 2010
- Efficacy of Sequential High-Dose Doxorubicin and Ifosfamide Compared With Standard-Dose Doxorubicin in Patients With Advanced Soft Tissue Sarcoma: An Open-Label Randomized Phase II Study of the Spanish Group for Research on SarcomasJournal of Clinical Oncology, 2009
- Synovial Sarcoma of the StomachAmerican Journal of Surgical Pathology, 2008
- Soft Tissue SarcomasCA: A Cancer Journal for Clinicians, 2004
- Epirubicin and doxorubicin: a comparison of their characteristics, therapeutic activity and toxicityCancer Treatment Reviews, 1993
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979